Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...
4don MSN
Cathie Wood's moves entering 2026: bets on gene-editing and genomics names, adds BEAM, TWST, NTLA
Cathie Wood’s latest moves entering 2026 focused on early-stage biotechnology firms while cutting exposure to consumer ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Dr. David Liu, pictured with former lab members Holly Rees ...
With 3,000 miles between them — and not much precedent behind the wheel — Stephen Dellaporta, in New Haven, CT, and Tom ...
The vast majority of consumers are open to purchasing gene-edited pork, according to new research from Circana, commissioned ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback